Clinical trial
Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00002656 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00002656 |
|---|---|
| Title | Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer |
| Official title | PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | pyrazoloacridine |
| Enrollment | 20 |
| Start date | Oct 1, 1995 |
| Primary completion | Dec 1, 2001 |
| Completion | Feb 1, 2008 |
| First posted | Jun 10, 2004 |
| Last update posted | Apr 29, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: